Is overall asthma control being achieved? A hypothesis-generating study

European Respiratory Journal

Volumn 17, Issue 4, 2001, Pages 589-595

  Bateman, E D ^a   Bousquet, J ^a   Braunstein, G L ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Asthma control; Budesonide; Drug therapy; Fluticasone propionate; Guidelines; Salmeterol

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL;

ARTICLE; ASTHMA; CLASSIFICATION; CLINICAL STUDY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DRUG RESPONSE; EXPECTATION; HUMAN; HYPOTHESIS; POWDER INHALER; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; DRUG COMBINATIONS; HUMANS; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; RESEARCH DESIGN;

EID: 0035011157     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17405890     Document Type: Article

References (21)

1. Global strategy for asthma management and prevention
2. The British guidelines on asthma management 1995 review and position statement
3. Guidelines for the diagnosis and management of asthma. Expert panel report 2
4. Association of asthma control with health care utilization and quality of life
5. Development and validation of a questionnaire to measure asthma control
6. Optimal asthma control, starting with high doses of inhaled budesonide
7. Measuring asthma control. Clinic questionnaire or daily diary?
8. Validation of a standardized version of the asthma quality of life questionnaire
9. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial
10. Combined salmeterol 50 μg and fluticasone propionate 250 μg in the Diskus device for the treatment of asthma
11. Salmeterol/fluticasone combination inhaler. A new, effective and well-tolerated treatment for asthma
12. Salmeterol and fluticasone propionate (50/250 mcg) administered via combination Diskus inhaler: As effective as when given via separate Diskus inhalers
13. Salmeterol/fluticasone propionate (50/500 μg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthma
14. Salmeterol/fluticasone propionate (50/100 μg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in children with asthma
15. Seretide (salmeterol 50 mcg/fluticasone propionate 100 mcg bid) compared with budesonide (400 mcg bid) in mild to moderate asthma
16. Salmeterol/fluticasone propionate combination therapy 50/250 μg twice daily is more effective than budesonide 800 μg twice daily in treating moderate to severe asthma
17. The asthma health outcome indicators study
18. What are minimal important changes for asthma measures in a clinical trial?
19. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma
20. The new single inhaler product containing both budesonide/formoterol improves asthma control in adults
21. Asthma control versus asthma severity